Radiopharmaceutical therapy and molecular imaging—together known as Theranostics—are gaining significant traction worldwide. Even though Theranostics dates back to the early 1940s, a rapid expansion ...

In this interview conducted at Pittcon 2023 in Philadelphia, Pennsylvania, we spoke to Ron Heeren, a speaker at the 2023 James L. Waters Symposium. Please could you introduce yourself, and tell us ...

Transitioning molecular imaging from a preclinical technique to a standard clinical tool could help detect the very earliest stages of disease, reports Tami Freeman Tools of the trade Left: this ...

Novel approaches in molecular imaging and targeted therapeutics are transforming the management of renal cell carcinoma (RCC) and urothelial carcinoma (UC). This review focuses on three key areas of ...

Molecular imaging is becoming a very interesting growth area in drug discovery. There is considerable enthusiasm in the preclinical market to expand the use of molecular imaging and a more cautious ...

Bayer bolsters development portfolio by acquisition of two investigational imaging agents (AT-01 and AT-05) from Attralus, Inc. to advance diagnosis for cardiac amyloidosis PET tracer AT-01 in Phase ...

CHICAGO & VANCOUVER, British Columbia--(BUSINESS WIRE)--GE Healthcare is proud to provide cutting-edge molecular imaging solutions that enable and increase access to precision health and theranostics ...

LOS ANGELES & RESTON, Va.--(BUSINESS WIRE)--The Prostate Cancer Foundation (PCF) and Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced a collaboration that will provide funding and ...

Imaging methods like X-ray, ultrasound and computed tomography (CT) are good at showing structures inside your body. They tell us about the size, shape and position of things. This includes both ...

Ronald Blasberg at Memorial Sloan-Kettering Cancer Center, Imaging of gene expression; Harvey Herschman at U. California, Los Angeles, Tracking of gene therapy, gene activities; David Piwnica-Worms at ...